A Texas-based phar­ma has en­list­ed Catal­ent for oral sol­id man­u­fac­tur­ing; Cy­ti­va drops mas­sive man­u­fac­tur­ing in­vest­ment in home state

CD­MO Catal­ent has kept busy with merg­ers and ac­qui­si­tions, but Mon­day, it an­nounced a col­lab­o­ra­tion with Dis­per­Sol to ac­cel­er­ate the man­u­fac­tur­ing of the com­pa­ny’s on­col­o­gy …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER